Suchergebnisse - "Mahévas, Matthieu"

PubPharm (4)

1

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists

enthalten in: Rheumatology (Oxford, England) | 2018

von Guitton, Z. | Terriou, L. | Lega, J. | +14

2

Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia

enthalten in: Blood | 2016

von Mahévas, M. | Gerfaud-Valentin, M. | Moulis, G. | +20

3

The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study

enthalten in: British journal of haematology | 2014

von Mahévas, M. | Fain, O. | Ebbo, M. | +8

4

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice : 2-year results of 72 adults in a romiplostim compassionate-use program

enthalten in: Blood | 2011

von Khellaf, M. | Michel, M. | Quittet, P. | +22

CommentIn: Blood. 2011 Oct 20;118(16):4297-8. - PMID 22021448

1
[1]